Terms: = Lymphoma AND TOP2A, TOP2, TP2A
23 results:
1. Bioinformatics analysis of the pathogenic link between Epstein-Barr virus infection, systemic lupus erythematosus and diffuse large B cell lymphoma.
Zhu QY
Sci Rep; 2023 Apr; 13(1):6310. PubMed ID: 37072474
[TBL] [Abstract] [Full Text] [Related]
2. ATM inhibitor KU60019 synergistically sensitizes lung cancer cells to topoisomerase II poisons by multiple mechanisms.
Shu J; Wang X; Yang X; Zhao G
Sci Rep; 2023 Jan; 13(1):882. PubMed ID: 36650267
[TBL] [Abstract] [Full Text] [Related]
3. Identification of joint gene players implicated in the pathogenesis of HTLV-1 and BLV through a comprehensive system biology analysis.
Ashrafi F; Ghezeldasht SA; Ghobadi MZ
Microb Pathog; 2021 Nov; 160():105153. PubMed ID: 34419613
[TBL] [Abstract] [Full Text] [Related]
4. Identification of Key Genes and Pathways Associated with Hepatosplenic T-Cell lymphoma (HSTCL) by Bioinformatics Analysis.
Du J; Lu G; Xu B; Han XL; Mou WW
Clin Lab; 2021 May; 67(5):. PubMed ID: 33978371
[TBL] [Abstract] [Full Text] [Related]
5. Polyketides from the marine-derived fungus Aspergillus falconensis: In silico and in vitro cytotoxicity studies.
El-Kashef DH; Youssef FS; Reimche I; Teusch N; Müller WEG; Lin W; Frank M; Liu Z; Proksch P
Bioorg Med Chem; 2021 Jan; 29():115883. PubMed ID: 33248353
[TBL] [Abstract] [Full Text] [Related]
6. top2a expression predicts responsiveness to carfilzomib in myeloma and informs novel combinatorial strategies for enhanced proteasome inhibitor cell killing.
Reale A; Khong T; Mithraprabhu S; Savvidou I; Hocking J; Bergin K; Ramachandran M; Chen M; Dammacco F; Ria R; Silvestris F; Vacca A; Reynolds J; Spencer A
Leuk Lymphoma; 2021 Feb; 62(2):337-347. PubMed ID: 33131357
[TBL] [Abstract] [Full Text] [Related]
7. The Indenoisoquinoline LMP517: A Novel Antitumor Agent Targeting both TOP1 and top2.
Marzi L; Sun Y; Huang SN; James A; Difilippantonio S; Pommier Y
Mol Cancer Ther; 2020 Aug; 19(8):1589-1597. PubMed ID: 32430490
[TBL] [Abstract] [Full Text] [Related]
8. Novel deazaflavin tyrosyl-DNA phosphodiesterase 2 (TDP2) inhibitors.
Kiselev E; Ravji A; Kankanala J; Xie J; Wang Z; Pommier Y
DNA Repair (Amst); 2020 Jan; 85():102747. PubMed ID: 31775111
[TBL] [Abstract] [Full Text] [Related]
9. Epigenetics evaluation of the oncogenic mechanisms of two closely related bovine and human deltaretroviruses: A system biology study.
Ashrafi F; Nassiri M; Javadmanesh A; Rahimi H; Rezaee SA
Microb Pathog; 2020 Feb; 139():103845. PubMed ID: 31698053
[TBL] [Abstract] [Full Text] [Related]
10. A systems medicine approach for finding target proteins affecting treatment outcomes in patients with non-Hodgkin lymphoma.
Ajorloo F; Vaezi M; Saadat A; Safaee SR; Gharib B; Ghanei M; Siadat SD; Vaziri F; Fateh A; Pazhouhandeh M; Vaziri B; Moazemi R; Mahboudi F; Rahimi Jamnani F
PLoS One; 2017; 12(9):e0183969. PubMed ID: 28892521
[TBL] [Abstract] [Full Text] [Related]
11. The efficacy and safety of gemcitabine, cisplatin, prednisone, thalidomide versus CHOP in patients with newly diagnosed peripheral T-cell lymphoma with analysis of biomarkers.
Li L; Duan W; Zhang L; Li X; Fu X; Wang X; Wu J; Sun Z; Zhang X; Chang Y; Nan F; Yan J; Li Z; Young KH; Zhang M
Br J Haematol; 2017 Sep; 178(5):772-780. PubMed ID: 28597542
[TBL] [Abstract] [Full Text] [Related]
12. Pathways of cardiac toxicity: comparison between chemotherapeutic drugs doxorubicin and mitoxantrone.
Damiani RM; Moura DJ; Viau CM; Caceres RA; Henriques JAP; Saffi J
Arch Toxicol; 2016 Sep; 90(9):2063-2076. PubMed ID: 27342245
[TBL] [Abstract] [Full Text] [Related]
13. Lack of topoisomerase copy number changes in patients with de novo and relapsed diffuse large B-cell lymphoma.
Pedersen MØ; Poulsen TS; Gang AO; Knudsen H; Lauritzen AF; Pedersen M; Nielsen SL; Brown P; Høgdall E; Nørgaard P
Exp Hematol; 2015 Jul; 43(7):534-6. PubMed ID: 25931012
[TBL] [Abstract] [Full Text] [Related]
14. The role of topoisomerase II beta on breakage and proximity of RUNX1 to partner alleles RUNX1T1 and EVI1.
Smith KA; Cowell IG; Zhang Y; Sondka Z; Austin CA
Genes Chromosomes Cancer; 2014 Feb; 53(2):117-28. PubMed ID: 24327541
[TBL] [Abstract] [Full Text] [Related]
15. BAF complexes facilitate decatenation of DNA by topoisomerase IIα.
Dykhuizen EC; Hargreaves DC; Miller EL; Cui K; Korshunov A; Kool M; Pfister S; Cho YJ; Zhao K; Crabtree GR
Nature; 2013 May; 497(7451):624-7. PubMed ID: 23698369
[TBL] [Abstract] [Full Text] [Related]
16. Sensitivity to top2 targeting chemotherapeutics is regulated by Oct1 and FILIP1L.
Lu H; Hallstrom TC
PLoS One; 2012; 7(8):e42921. PubMed ID: 22900064
[TBL] [Abstract] [Full Text] [Related]
17. Expression of p53, Ki-67, E-cadherin, N-cadherin and top2a in triple-negative breast cancer.
Nakagawa M; Bando Y; Nagao T; Morimoto M; Takai C; Ohnishi T; Honda J; Moriya T; Izumi K; Takahashi M; Sasa M; Tangoku A
Anticancer Res; 2011 Jun; 31(6):2389-93. PubMed ID: 21737670
[TBL] [Abstract] [Full Text] [Related]
18. Multilocus association of genetic variants in MLL, CREBBP, EP300, and top2a with childhood acute lymphoblastic leukemia in Hispanics from Texas.
Piwkham D; Gelfond JA; Rerkamnuaychoke B; Pakakasama S; Rebel VI; Pollock BH; Winick NJ; Collier AB; Tomlinson GE; Beuten J
Cancer Epidemiol Biomarkers Prev; 2011 Jun; 20(6):1204-12. PubMed ID: 21493871
[TBL] [Abstract] [Full Text] [Related]
19. [Preliminary study of gene expression profile associated with risk classification of childhood patients with acute lymphoblastic leukemia].
Wang JL; Chai YH; Ji ZH; Shao XJ; Huang YP
Zhonghua Xue Ye Xue Za Zhi; 2011 Jan; 32(1):29-33. PubMed ID: 21429398
[TBL] [Abstract] [Full Text] [Related]
20. Identification of a proliferation signature related to survival in nodal peripheral T-cell lymphomas.
Cuadros M; Dave SS; Jaffe ES; Honrado E; Milne R; Alves J; Rodríguez J; Zajac M; Benitez J; Staudt LM; Martinez-Delgado B
J Clin Oncol; 2007 Aug; 25(22):3321-9. PubMed ID: 17577022
[TBL] [Abstract] [Full Text] [Related]
[Next]
